Evidence map›Paper›PMID 18695980›Full record

ArticleEuropean journal of clinical pharmacology2008

A clinical evaluation of the Janus Web Application, a software screening tool for drug-drug interactions.

Buster Mannheimer, Johanna Ulfvarson, Sara Eklöf, Monica Bergqvist, Christer von Bahr

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Buster MannheimerDepartment of Internal Medicine, Karolinska Institutet, Södersjukhuset, SE-11883, Stockholm, Sweden. buster.mannheimer@sodersjukhuset.se
Johanna Ulfvarson
Sara Eklöf
Monica Bergqvist
Christer von Bahr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the clinical relevance of the Janus Web Application (JWA) in screening for potential drug-drug interactions (DDIs).

methodsOne hundred and fifty patients taking two drugs or more were studied. Potential DDIs were identified by the JWA. Interviewing the patient and looking into his/her medical records provided complementing information. A clinical pharmacologist judged which potential DDIs were clinically relevant. Potentially relevant DDIs identified by the JWA were then correlated with clinically relevant DDIs.

resultsA total of 150 significant potential DDIs were found. Sixteen percent (24/150) were judged to be clinically relevant.

conclusionsA very small proportion of DDIs was considered clinically relevant in the specific clinical context. To optimise the software's user-friendliness, the following points need to be considered: the possibility of eliminating trivial potential DDIs, individualising drug alerts, and providing written information, accessible via a hyperlink.

Indexed as

Decision Support Systems, ClinicalDrug InteractionsDrug Utilization ReviewPharmaceutical PreparationsSoftwareAgedDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMedical RecordsSurveys and QuestionnairesSwedenPharmaceutical Preparations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.